Overview
- ANLIS sequenced 119 samples from 16 jurisdictions and found 30% were XFG and 14.4% were LP.8.1, confirming the recombinant variant’s expansion.
- WHO data show XFG accounted for 66.4% of global sequenced Covid-19 cases as of September 14.
- Recent surveillance placed SARS‑CoV‑2 detections above influenza and second among respiratory viruses behind RSV.
- Reports cite no evidence of increased virulence, and national bulletins describe low and stable hospitalizations.
- Only 6,438 Covid vaccine doses were administered nationwide from September 18 to October 2, with half in Buenos Aires and CABA, while 13.7 million doses have arrived since early 2023 and 5.8 million have been used.